All Activity

New Hampshire lawmakers on Wednesday took up a pair of bipartisan bills to legalize the regulated use of psilocybin for medical purposes. At a hearing before the House Health, Human Services and Elderly Affairs Committee, members heard public testimony on the proposals: HB 1809 from Rep. Buzz Scherr (D) and HB 1796 from Rep. Michael Moffett (R). Both measures seek to create a regulatory pathway for patients with certain conditions to access the psychedelic for therapeutic use through a program overseen by the state Department of Health and Human Services (DHHS). But Moffett’s legislation is more prescriptive about the proposed regulatory framework. “I am an unlikely prime sponsor for a measure such as this,” Moffett told fellow lawmakers at the hearing, saying he’s “always been very wary and skeptical of” psychedelics and has “always been a hard no on marijuana for many reasons, to include the fact that I was constantly drug tested myself for many years in the Marine Corps, where I developed a zero tolerance for illegal drug use.” He said that he changed his mid after seeing a presentation on psychedelic therapies at a national veterans conference last summer, where he learned that “a psilocybin treatment option could have value to almost anyone, beyond military people or former military people.” Scherr, for his part, said there’s a “substantial amount of research going on currently about the therapeutic uses of psilocybin.” “The research in terms of it helping with those who have treatment-resistant depression is pretty significant at this point,” he said. “Research in terms of broader use for those suffering from other forms of PTSD is developing. Research for use with people who have certain forms of substance abuse is also developing.” Jenny O’Higgins of the state Department of Health and Human Services said officials have some concerns around the lack of appropriated funds in Moffett’s legislation, saying the department would “not be able to absorb” the program under its current budget. A representative of the prohibitionist organization Smart Approaches to Marijuana’s New Hampshire affiliate testified against the proposals, saying that psilocybin is a federally illegal Schedule I drug. She also argued that there is insufficient evidence to support the psychedelic’s therapeutic potential. Here are the key provisions of HB 1809: DHHS would be responsible for approving licensed medical professional to serve as providers of psilocybin for qualifying patients. In order to qualify for the program, patients would need to be diagnosed with treatment-resistant depression, post-traumatic stress disorder (PTSD), substance use disorder or another condition authorized by an advisory board and DHHS. The legislation specifically stipulates that only natural psilocybin could be administered, excluding synthetic versions of the psychedelic. Providers would also need to be approved by the department to grow and harvest their own psilocybin products. The process for treating qualifying patients with the psychedelic would need to involve a preparation session, administration session and integration session. A Medical Psilocybin Advisory Board would be established, comprised of a representative of DHHS, a qualifying patient, a veterans advocate and eight medical professionals. Those medical experts would need to include a psychedelics researcher, two regulators overseeing existing medical psilocybin programs and specialists in the treatment of addiction, palliative care, veterans’ affairs, naturopathy, nursing and mental health counseling. The board would be tasked with analyzing data on patient outcomes from DHHS, consider adding qualifying conditions for participation in the program and determine whether the law should be expanded. The program would only be implemented if the advisory board, within two years of the bill’s enactment, notifies lawmakers, regulators and the governor that it can be effectively administered. “The medical community has always recognized that patients exist with serious conditions that are very resistant to effective treatment,” a statement of purpose for the measure says. “Recently, research has begun to show that certain of those patients have had positive results with the closely supervised use of psilocybin for treatment.” “Patients with significant post-traumatic stress disorder, with treatment-resistant clinical depression, and with serious substance use disorder have been shown to benefit from the controlled, therapeutic use of psilocybin in a supervised setting,” it says. “The purpose of this act is to create a carefully monitored and closely supervised setting in which an approved medical provider can treat a carefully chosen patient with appropriate doses of psilocybin which that same provider has produced for a medical intervention.” Here are the main details of HB 1796: The bill would permit the regulated use of psilocybin in a medically supervised setting, with DHHS responsible for overseeing the program. To qualify for psilocybin treatment, a patient 21 or older would need to be diagnosed with treatment-resistant depression, PTSD, substance misuse disorder, a terminal illness requiring end-of-life care or any other condition authorized by DHHS. A Psilocybin Licensing Board under the department would be tasked with issuing licenses for independent medical psilocybin providers, therapy providers, cultivators and testing laboratories. There would be specific guidelines for facilities where the psychedelic could be administered, including security requirements and other safety protocols such as ensuring there are rescue medications on site if a patient experiences an adverse event. The legislation would also establish a Therapeutic Psilocybin Treatment Fund, which would be funded by revenue from licensing taxes and fees. The fund would go toward studies into the possibility of expanding the program to include additional psychedelics in the program. The law if enacted would take effect beginning in January 1, 2027. “The purpose of the Therapeutic Psilocybin Act is to allow the beneficial use of psilocybin in a regulated system for alleviating qualified medical conditions,” the bill’s statement of purpose says. The prospects of either bill advancing this session remain unclear, but lawmakers have been increasingly active in pursuing psychedelics reform in recent years. Last June, the New Hampshire Senate voted to scrap compromise legislation that would have lowered the state’s criminal penalty for first-time psilocybin possession while also creating mandatory minimum sentences around fentanyl. As originally introduced, the legislation would have completely removed penalties around obtaining, purchasing, transporting, possessing or using psilocybin, effectively legalizing it on a noncommercial basis. However a House committee amended the bill before unanimously advancing it last March. Meanwhile in New Hampshire, the House last week approved a bill to legalize marijuana in the state—though its chances of passage in the Senate remain dubious, and the governor has expressed clear opposition to the reform. Also last week, the chamber passed a proposal to allow medical cannabis dispensaries to become for-profit businesses. The legalization bill, sponsored by Rep. Jared Sullivan (D), is one of several cannabis proposals filed for the 2026 session, including legislation from Rep. Jonah Wheeler (D) that seeks to put a constitutional amendment on the state ballot that would let voters decide if they want to legalize marijuana for adults 21 and older, allowing them to “possess a modest amount of cannabis for their personal use.” Gov. Kelly Ayotte (R) has already threatened to veto any legalization bill that reaches her desk, though the constitutional amendment proposal would not require gubernatorial action. The governor said in August that her position on the reform would not change even if the federal government moved forward with rescheduling the plant. Since then, President Donald Trump has directed the attorney general to finalize the process of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). At a committee meeting last year, Sullivan ultimately made a persuasive argument for advancing his legalization bill, pointing out that the House has repeatedly passed similar legislation and that the chamber should stand its ground, forcing the Senate and governor to again go on record with their opposition to a policy popular among voters. “We know where it’s going to go. Let’s send a virtue signal,” Sullivan said. “Let them be the ones that are pissing off voters who care about this.” Meanwhile, the House also approved a bill last week from Rep. Wendy Thomas (D) that would allow medical marijuana dispensaries (known as “alternative treatment centers,” or ATCs, in the state) to convert their dispensary licenses to become for-profit entities. HB 54, which passed on the consent calendar with other legislation, previously advanced unanimously out of the House Finance Committee. Part of the motivation behind the legislation is the fact that medical marijuana dispensaries don’t qualify for federal non-profit status. But in the state, they’re considered non-profit organizations, which has resulted in disproportionately increased operating costs. Other bills filed for 2026 include two proposals to protect the gun rights of medical cannabis patients. There are also a few pieces of legislation aimed at regulating hemp sales—an issue that’s receiving heightened attention given that Congress passed, and Trump signed, an appropriations bill that would effectively re-criminalize most consumable hemp products. Meanwhile, after the House added provisions to a Senate-passed bill last year that would allow medical marijuana patients to grow cannabis at home, those measures were stripped in conference. Image courtesy of CostaPPR. The post New Hampshire Lawmakers Take Up Bipartisan Bills To Legalize Psilocybin For Medical Use appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New Jersey’s Senate president has filed a bill that would allow marijuana companies to engage in interstate commerce. Under the proposal from Sen. Nicholas Scutari (D), the governor would be empowered to “enter into an agreement with another state or states authorizing medicinal or personal-use commercial cannabis activity, or both, between entities licensed under the laws of the contracting state and entities operating with a State license” in New Jersey. However, the reform would only take effect under certain conditions, such as if federal law changed to explicitly allow interstate marijuana commerce, the U.S. Department of Justice issued a memo saying it would tolerate the activity or if Congress passed legislation blocking officials from enforcing the prohibition on cannabis sales between states. Alternatively, the policy could move forward if the state attorney general issued an opinion determining that the law’s implementation “will not result in significant legal risk to this State based on review of federal judicial decisions and administrative action.” Cannabis products brought into the state from another market under the bill’s framework would need to be subject rules equivalent to New Jersey’s regulations, including with respect to testing, packaging, labeling, marketing, tracking and quality assurance. Scutari has introduced interstate cannabis commerce legislation in previous sessions, but none of those proposals were enacted into law. Several other states already have interstate marijuana commerce laws in place. California Gov. Gavin Newsom (D), for example, signed a bill in 2022 that empowers him to enter into interstate cannabis commerce agreements with other legal states, but that power is incumbent upon federal guidance or an assessment from the state attorney general that sanctioned such activity. Following a review of the policy proposal, however, California Attorney General Rob Bonta’s (D) office ultimately determined in 2023 that the state could put itself and its employees at “significant legal risk” of federal enforcement action if it were to authorize interstate marijuana commerce. Oregon and Washington State have also passed laws allowing officials to enter into cross-border cannabis trade agreements with other states, although those state laws both require some form of federal reform or guidance to proceed. Meanwhile, lawmakers in Congress have filed legislation intended to help small marijuana growers compete against large corporations in the event of federal legalization—proposing to give them the ability to ship and sell cannabis products directly to consumers within and across state lines via the U.S. Postal Service (USPS) and commercial carriers. Back in New Jersey, lawmakers this week sent Gov. Phil Murphy (D) a bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the effort. In other New Jersey drug policy news, voters in November elected U.S. Rep. Mikie Sherrill (D-NJ) to serve as the state’s next governor, and there’s now a decidedly clearer path to advancing a marijuana reform long awaited by consumers and advocates in the Garden State: A home grow option. Meanwhile, as New Jersey’s first marijuana consumption lounges opened up over the summer, regulators shared information about where to find the sites and offering tips about how to responsibly use cannabis at the licensed businesses—including classic stoner cultural customs like “puff, puff, pass.” New Jersey officials have also completed the curriculum of a no-cost marijuana training academy that’s meant to support entrepreneurs interested in entering the cannabis industry. The post New Jersey Marijuana Businesses Could Engage In Interstate Commerce Under Senate President’s New Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Ohio’s attorney general has rejected activists’ referendum petition to block parts of a restrictive marijuana and hemp law from going into effect, saying its summary is “misleading” and must be revised in order to proceed. “Upon review of the summary, we identified omissions and misstatements that, as a whole, would mislead a potential signer as to the scope and effect of S.B. 56,” Attorney General Dave Yost (R) wrote in a letter to the petitioners on Tuesday. The referendum, led by Ohioans for Cannabis Choice, seeks to repeal key components of a bill the governor recently signed to scale back the state’s voter-approved marijuana law and ban the sale of consumable hemp products outside of licensed cannabis dispensaries. The group submitted an initial batch of 1,000 signatures to get the referendum process started last month. Yost said that several aspects of the petition summary are misleading. For example it contains “two very similar descriptions” of the definition of hemp, the attorney general said, meaning that “a potential signer would likely be misled as to the character and import of this definition.” The submission also “inaccurately” states that SB 56 “permits delivery of adult use cannabis,” Yost said. “Nowhere in the bill is the division of cannabis control authorized to adopt rules on the delivery of adult-use cannabis.” The summary additionally “inaccurately states that felony offenses are disqualifying for cannabis-related licensure,” the letter claims, pointing out that Gov. Mike DeWine (R) vetoed that provision and it is thus not part of the enacted law. “The summary inaccurately states S.B. 56 repealed a prohibition of license holders offering gifts, samples or other free or discounted adult-use marijuana products,” Yost added. “This is false. First, no such prohibition was repealed by S.B. 56. Instead, the bill directs the division of cannabis control to ‘establish standards prohibiting the use of gifts, samples, or other free or discounted goods or services to induce or reward a license holder for business or referrals.'” Also, the petition “misleads the reader into believing that S.B. 56 gives local governments the authority to pass ordinances that prohibit or limit the rights of license holders and/or prohibit other activities that are permitted under statewide cannabis control laws,” the attorney general’s letter says. Finally, Yost said that the petition summary “incorrectly states” that the bill authorizes local governments to levy excise taxes on recreational cannabis sales. “The above instances are just a few examples of the summary’s omissions and misstatements, and further review will be undertaken should the matter be resubmitted,” Yost told organizers in the letter. Dennis Willard, spokesperson for Ohioans for Cannabis Choice, said the campaign will “fix the language, collect an additional 1,000 signatures, and not slow down.” “Voters this November will have the opportunity to say no to S.B. 56, no to government overreach, no to closing 6,000 businesses and abandoning thousands of Ohio workers, and no to defying the will of Ohioans who overwhelmingly supported legalizing cannabis in 2023,” he said. DeWine’s office and a senator who led the charge to pass SB 56 have criticized the cannabis referendum campaign. If and when the resubmitted petition is approved for broader circulation, the campaign will need to collect a total of about 250,000 signatures to make the ballot. In general, the proposed referendum would repeal the first three core sections of SB 56, a controversial bill that DeWine signed into law last month that he says is intended to crack down on the unregulated intoxicating hemp market. But the legislation would do more than restrict the sale of cannabinoid products to dispensaries. The law also recriminalizes certain marijuana activity that was legalized under the ballot initiative voters approved in 2023, and it’d additionally remove anti-discrimination protections for cannabis consumers that were enacted under that law. The governor additionally used his line-item veto powers to cancel a section of the bill that would have delayed the implementation of the ban on hemp beverages. Advocates and stakeholders strongly protested the now-enacted legislation, arguing that it undermines the will of voters who approved cannabis legalization and would effectively eradicate the state’s hemp industry, as there are low expectations that adults will opt for hemp-based products over marijuana when they visit a dispensary. The pushback inspired the newly filed referendum—but the path to successfully blocking the law is narrow. If activists reach the signature threshold by the deadline, which coincides with the same day the restrictive law is to take effect, SB 56 would not be implemented until voters got a chance to decide on the issue at the ballot. A summary of the submitted referendum states that “Sections 1, 2, and 3 of Am. Sub. S. B. No. 56 enact new provisions and amend and repeal existing provisions of the Ohio Revised Code that relate to the regulation, criminalization, and taxation of cannabis products, such as the sale, use, possession, cultivation, license, classification, transport, and manufacture of marijuana and certain hemp products.” “If a majority of the voters vote to not approve Sections 1, 2, and 3 of the Act, then the enacted changes will not take effect and the prior version of the affected laws will remain in effect,” it says. Advocates have flagged a series of concerns with the law, pointing out, for example, that it would eliminate language in statute providing anti-discrimination protections for people who lawfully use cannabis. That includes protections meant to prevent adverse actions in the context of child custody rights, the ability to qualify for organ transplants and professional licensing. It would also recriminalize possessing marijuana from any source that isn’t a state-licensed dispensary in Ohio or from a legal homegrow. As such, people could be charged with a crime for carrying cannabis they bought at a legal retailer in neighboring Michigan. Additionally, it would ban smoking cannabis at outdoor public locations such as bar patios—and it would allow landlords to prohibit vaping marijuana at rented homes. Violating that latter policy, even if it involves vaping in a person’s own backyard at a rental home, would constitute a misdemeanor offense. The legislation would also replace what had been a proposed regulatory framework for intoxicating hemp that the House had approved with a broad prohibition on sales outside marijuana dispensaries following a recent federal move to recriminalize such products. Under the law, hemp items with more than 0.4 mg of total THC per container, or those containing synthetic cannabinoids, could no longer be sold outside of a licensed marijuana dispensary setting. That would align with a recently enacted federal hemp law included in an appropriations package signed by President Donald Trump. The federal law imposing a ban on most consumable hemp products has a one-year implementation window, however, and it appears the Ohio legislation would take effect sooner. As passed by the legislature, a temporary regulatory program for hemp beverages would have stayed in place in Ohio until December 31, 2026, but that provision was vetoed by the governor. The law also includes language stipulating that, if the federal government moves to legalize hemp with higher THC content, it’s the intent of the Ohio legislature to review that policy change and consider potential state-level reforms to regulate such products. The bill signing came months after DeWine issued emergency rules prohibiting the sale of intoxicating hemp products for 90 days, with instructions to the legislature to consider permanent regulations. A county judge has enjoined the state from enforcing that policy in response to a legal challenge. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, in September, the Ohio Department of Cannabis Control (DCC) filed proposed rules to build upon the state’s marijuana legalization law, laying out plans to update regulations on labeling and packaging requirements. Ohio retailers sold more than $1 billion worth of legal marijuana products in 2025, according to data from the state Department of Commerce (DOC). In March, a survey of 38 municipalities by the Ohio State University’s (OSU) Moritz College of Law found that local leaders were “unequivocally opposed” to earlier proposals that would have stripped the planned funding. Meanwhile in Ohio, adults as of June are able to buy more than double the amount of marijuana than they were under previous limits, with state officials determining that the market can sustainably supply both medical cannabis patients and adult consumers. The governor in March separately announced his desire to reallocate marijuana tax revenue to support police training, local jails and behavioral health services. He said funding police training was a top priority, even if that wasn’t included in what voters passed in 2023. The post Ohio Attorney General Rejects Cannabis Referendum Petition, Saying It’s ‘Misleading’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

SteamUnlocked is the official site for downloading free pre-installed PC games. Explore clean, fast, and verified downloads across every genre. https://steamunlocked.org/

Totals Bets on the total number of goals, points, or sets. The bettor must correctly guess whether the actual result will be over or under a specified number. 1xbet casino promo code hong kong

It’s been eight years since Canada legalized marijuana nationwide, and a new poll shows that support for the reform is increasing over time. Relatively few Canadians want to legalize other drugs, however. Roughly two-thirds of Canadian adults (65 percent) now say they agree with cannabis being legal, according to the survey from Research Co. That’s up three percentage points since the firm last polled on the topic in 2024. Just 29 percent of respondents disagree with marijuana legalization, and 6 percent say they’re not sure how they feel about the reform. The survey, which was conducted from December 7-9, 2025, and involved online interviews with a representative sample of 1,002 adults in Canada, shows that there is majority support for cannabis being legal in each geographic and racial demographic breakdown reported by the pollster. Thirty-six percent of respondents say they consumed marijuana prior to it becoming legal, 15 percent used it only after legalization and 49 percent say they have never tried it. Among those who have used cannabis since it was legalized in October 2018, 48 percent say all of it was acquired at a licensed retailer, 17 percent say most it was from a legal shop, 13 percent got some of it from a licensed store and 16 percent got all of their cannabis outside the legal retail system. Despite growing majority support for legal marijuana, only a minority of Canadians support legalizing other drugs such as MDMA (14 percent), powder cocaine (12 percent), crack cocaine (10 percent), meth (10 percent), heroin (9 percent) and fentanyl (9 percent), the poll shows. When asked whether companies should be able to drug test employees for marijuana, 34 percent said they definitely should, 30 percent said they probably should, 14 percent said probably not and 13 percent said definitely not. “There is no political divide when Canadians are asked about drug tests for employees,” Mario Canseco, President of Research Co., said in a press release. “Majorities of respondents who voted for the Conservatives (69%), the Liberals (68%) or the New Democrats (58%) in 2025 think the measure is justified now that marijuana is legal.” The poll has a 3.1 percentage point margin of error. A survey released last year also showed that a majority of Canadians feel the marijuana sector that’s emerged since cannabis was legalized nationwide is an “important contributor” to the country’s economy. Canadians seem to recognize the value of the cannabis industry to the country’s overall financial health, with 59 percent describing the sector as a valuable component of the economy. That includes 69 percent of recent Liberal voters and 58 percent of recent Conservative voters. When the research firm and Organigram last asked Canadians that question last April, 57 percent agreed about the importance of the marijuana market relative to the national economy, so this represents a slight increase. Observers have also been watching how broader adult-use legalization impacts medical marijuana in Canada, noting, for example, patient enrollment rates declining after legalization was enacted but before retailers opened for business. A study released last year, meanwhile, found similar marijuana use rates and support for legalization in both the U.S. and Canada despite the countries’ different national approaches to regulating the drug. Another report last year found that marijuana legalization was “associated with a decline in beer sales,” suggesting a substitution effect where consumers shift from one product to the other. Meanwhile, a separate survey out of Canada that was financially supported by the government recently found that youth marijuana use rates have declined after the country legalized cannabis—contradicting concerns voiced by prohibitionists. A separate Canadian government report found that daily or near-daily use rates by both adults and youth have held steady over the last six years after the country enacted legalization. The post Canadian Support For Marijuana Legalization Is Increasing, New Poll Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

It is my first visit to your blog, and I am very impressed with the articles that you serve. Give adequate knowledge for me. Thank you for sharing useful material. I will be back for the more great post. 강남쩜오

Choosing the right events to bet on involves focusing on popular sports and significant matches. To bet wisely, a player should understand the rules of the sport and have basic knowledge of team statistics. It’s also important to: promo code 1xbet ethiopia

Great post, you have pointed out some excellent points, I as well believe this is a very superb website. 강남쩜오

Very useful — I appreciated screenshots of active marketplace trades. A healthy market signals a living, breathing server economy. Real player rankings verified those observations. 강남가라오케

Joe Rogan seemed stunned to hear Sen. Rand Paul (R-KY) tell him on a new episode of his podcast that certain marijuana businesses joined hands with the alcohol industry to lobby in favor of a federal ban on most hemp THC products. During a wide-ranging interview on the Joe Rogan Experience that aired on Tuesday, the senator discussed his months-long effort to fight against the recriminalization of hemp under a spending bill signed into law by President Donald Trump in November. Paul again faulted his home-stare colleague Sen. Mitch McConnell (R-KY) for spearheading the ban, which hemp industry stakeholders say would effectively eradicate the industry that’s evolved since the crop was federally legalized under the 2018 Farm Bill that Trump signed during his first term. “He is very, very powerful, and a lot of people owe him,” Paul said. “He raised money for decades—hundreds of millions of dollars, passed it out to the lesser-known senators and helped them get elected when they would get challenges—and so then they all owe him.” While he faced criticism from some after holding up the appropriations legislation over the hemp provisions, Paul said it was his “only choice” to protect the market after McConnell’s prohibitionist language was inserted. Rogan asked whether the alcohol industry also played a role in lobbying for the ban. Paul didn’t disagree, but he said it was a “little bit” of influence from alcohol interests combined with some in the marijuana industry who have grown frustrated that hemp’s federally legal status means its producers can market across state lines while marijuana remains federally prohibited, with interstate commerce banned. “The cannabis people hate the hemp people,” Paul said, while adding that the competitive conflict is “complicated.” “The cannabis industry developed state-by-state—and you really can’t make a marijuana product in Colorado and sell it in Kentucky,” he said. “It can’t go across state lines. The hemp, because it was legalized nationally, they were selling it across state lines. So we have big companies now that sell the hemp. You can order them through the mail, across state lines, until this law came about.” “McConnell always felt it was an unintended consequence. And some of the growth [of the industry] might have been, but I don’t think it was,” he continued. “There were some bad products out there, and all of us, including [hemp stakeholders], said, ‘Alright, let’s regulate this. Let’s not have 100 milligram gummies.'” Marijuana businesses would “probably accept” the competition with the hemp industry if marijuana was federally legal, the senator said, but “we’ve legalized it state-by-state.” Rogan and Paul also spoke more broadly about what they suggested is the hypocrisy of the hemp ban given that people who may benefit from cannabinoids like CBD and THC would lose access, even as pharmaceutical drugs with potentially harmful side effects have long been legally marketed and sanctioned by federal health officials. “They’re protecting you so you can take Ambien, but god forbid you take a hemp gummy. They will put your ass in jail if you take a hemp gummy,” Paul said. “So all the plants are illegal now. All the seeds are illegal. There’s a real industry of farmers who grow this. And the thing is, who are we to tell somebody who can’t sleep at night that an Ambien is better for them than than taking a hemp gummy to go sleep at night? Or a veteran who could take Percocet or some kind of psychotropic drug—or who has anxiety or post-traumatic stress—and we’re going to tell them they can’t take a hemp gummy? I think it’s insane and very much this presumption that we know what’s best for everyone.” The senator said that he hasn’t personally used hemp products despite his advocacy for the industry and personal liberties around cannabis consumption. “I’m for the freedom to take it, but I sleep pretty good,” he said. “It’s not really something I can attest to exactly how it works, but people who do take it tell me that have one of the drinks [and] it might be like drinking a beer, or maybe not even drinking a beer, when you drink one of these THC drinks.” He also explained that one of the issues with the newly enacted law prohibiting most consumable cannabinoids derived from hemp, which is set to take effect next November, would likely make it so patients and consumers wouldn’t want to buy them anymore because of the severely restrictive THC limits. “The McConnell language says you can’t have more than 0.4 milligrams [of THC], which is such a low number that I don’t think will have any effect. I mean, frankly, the THC is the effect,” Paul said. “And so if you make the THC number so small, I don’t think people will take them. The CBD oil people might still take some of that, but I assume that the effect that people are getting from the CBD oil, if they rub it on, has to be the THC.” CBD on its own may still hold therapeutic potential for some patients, he acknowledged, but the way the law is written would re-criminalize levels of hemp THC at the plant- and seed-level, too. That means farmers would “have to re-hybridize all these plants” in order to stay in compliance. Rogan, for his part, noted that his mother-in-law uses hemp-derived oil to treat symptoms of arthritis, and she’s found it significantly more effective when the non-intoxicating CBD contains small amounts of THC. A friend of Rogan’s said the same principle has applied to his child with autism who sometimes experiences seizures. Scientists have described this multi-cannabinoid experience as the entourage effect, where the compounds appear to be more effective when combined rather than isolated. The senator also emphasized that he’s “not here to tell you to take [cannabis] or not take it. I’m for the freedom for people to make their own decision.” Paul also joked about how he often tells people that the same lawmakers who stand firmly opposed to letting people access cannabis must have attended the premiere of Reefer Madness in the 1930s and accepted the sensationalized claims about marijuana use as fact, without even challenging that narrative. Rogan then shared a history lesson about the origins of the marijuana prohibitionist push, including the influence of a former publishing magnate, William Randolph Hearst, whose newspapers peddled various claims stigmatizing cannabis after technology developed to refine hemp as a paper alternative that threatened his company’s bottom line. In positive news for hemp stakeholders, a Republican congressman this week introduced a bill that would give the hemp industry two more years before the federal ban on THC products would take effect, which stakeholders hope will better position them to negotiate a broader compromise with lawmakers. Several bipartisan lawmakers, including the lead sponsor, protested as the spending legislation with the hemp ban provision advanced through Congress. For what it’s worth, four in five marijuana consumers say they oppose the recriminalization of hemp THC products under the spending bill Trump signed. However, it should be noted that that poll was conducted weeks before he issued a cannabis rescheduling order and took steps to protect access to full-spectrum CBD. Trump signed an executive order last month directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). Part of that announcement also hold implications for the forthcoming hemp law. The president’s order also urged Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients. A further redefinition of hemp would be part of a novel proposal to allow Medicare recipients to access non-intoxicating CBD that’d be covered under the federal health care plan. To effectuate that, the Centers for Medicare & Medicaid Services (CMS) will be announcing “a model that will allow a number of CMS beneficiaries to benefit from receiving CBD under doctor recommendation at no cost,” a White House official said during a briefing that Marijuana Moment first reported leaked details from ahead of the signing event. Trump seemed endorse a more flexible CBD policy last summer when he shared a video calling for that specific reform while promoting the health benefits of cannabidiol, particularly for seniors. Meanwhile, a separate recently filed Republican-led congressional bill would stop the implementation of the hemp ban under the enacted appropriations legislation. Hemp businesses and industry groups have warned about the potential ramifications of the ban, but despite his support for states’ rights for cannabis and a recent social media post touting the benefits of CBD, Trump signed the underlying spending measure into law without acknowledging the hemp provisions. GOP political operative Roger Stone said recently that Trump was effectively “forced” by Republican lawmakers to sign the spending bill with the hemp THC ban language. However, a White House spokesperson said prior to the bill signing that Trump specifically supported the prohibition language. The Democratic governor of Kentucky said that the hemp industry is an “important” part of the economy that deserves to be regulated at the state level—rather than federally prohibited, as Congress has moved to do. Also, a leading veterans organization is warning congressional leaders that the newly approved blanket ban on consumable hemp products could inadvertently “slam the door shut” on critical research. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC on a dry weight basis. The new legislation specifies that, within one year of enactment, the weight will apply to total THC—including delta-8 and other isomers. It will also include “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).” The new definition of legal hemp will additionally ban “any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or not capable of being naturally produced by it. Legal hemp products will be limited to a total of 0.4 milligrams per container of total THC or any other cannabinoids with similar effects. Within 90 days of the bill’s enactment, the Food and Drug Administration (FDA) and other agencies will need to publish list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature,” “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and “all other known cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.” The language slightly differs from provisions included in legislation that had previously advanced out of the House and Senate Appropriations panels, which would have banned products containing any “quantifiable” amount of THC, to be determined by the HHS secretary and secretary of agriculture. Image element courtesy of Joe Rogan. The post Joe Rogan Surprised After GOP Senator Says Marijuana And Alcohol Industries Jointly Backed Push To Ban Hemp THC Products appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

All the contents you mentioned in post is too good and can be very useful. I will keep it in mind, thanks for sharing the information keep updating, looking forward for more posts.Thanks 강남쩜오

We have sell some products of different custom boxes.it is very useful and very low price please visits this site thanks and please share this post with your friends. SITUS TOGEL

howdy, your websites are really good. I appreciate your work. helibeauty

Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. ดูหนัง Netflix Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. ดูมวยออนไลน์ Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. แทงวัวชนออนไลน์ I love how these outfits combine style and precision tailoring. Personalized latex designs make every piece feel special. The high-gloss finish looks incredibly sleek. Fast global delivery is a big advantage. แทงไก่ชนออนไลน์ The 323 feels like the heartbeat of L.A. neighborhoods that shaped so much of California culture. demo pg soft This guide is really helpful for understanding how the 323 ties together such diverse communities. togel online Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. x5bet game Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. istanbul beauty salon Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. https://www.037hdmovie.xyz I love how these outfits combine style and precision tailoring. Personalized latex designs make every piece feel special. The high-gloss finish looks incredibly sleek. Fast global delivery is a big advantage. เว็บแทงมวย ที่น่าเชื่อถือที่สุดในไทย The 323 feels like the heartbeat of L.A. neighborhoods that shaped so much of California culture. ผลวัวชนอัปเดต This guide is really helpful for understanding how the 323 ties together such diverse communities. ดูไก่ชนออนไลน์ ดูสดฟรีในเว็บเดียว Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. togel online Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. togel online

Fed official: Teen marijuana access down as more states legalize; NJ psilocybin bill to gov; IN legalization poll; Cannabis existential threat op-ed Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Rep. Jim Baird (R-IN) and four bipartisan cosponsors filed a bill to delay implementation of the impending federal recriminalization of hemp THC products for another two years. A federal official with the National Institute on Drug Abuse spoke about how an annual survey shows that teens are finding it harder to access marijuana and are more disapproving of use even as legalization spreads—contrary to fears voiced by prohibitionists. New Jersey lawmakers sent Gov. Phil Murphy (D) a bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the psychedelic treatment and research effort. A new poll of Indiana residents shows that 84 percent support legalizing medical cannabis and that 59 percent also want to legalize recreational marijuana. Marijuana Policy Project Executive Director Adam Smith argues in a new Marijuana Moment op-ed that ballot initiatives to roll back legalization in Arizona, Maine and Massachusetts are the “first-ever large-scale coordinated attack on adult-use markets” and that the cannabis industry needs to fight back. Maine Secretary of State Shenna Bellows (D) told lawmakers that her office would inform a campaign seeking to roll back marijuana legalization that it has received a significant number of complaints about misleading petitioning tactics. / FEDERAL Former Republican presidential candidate Steve Forbes said marijuana is “five times more lethal” than when he was growing up and “can do immense damage.” The U.S. Department of Agriculture clarified that cannabis that does not meet the definition of hemp is not eligible to be covered by the Agriculture Risk Coverage and Price Loss Coverage programs. The House bill to create a pathway for patients to access Schedule I drugs got one new cosponsor for a total of 13. / STATES New Jersey Gov. Phil Murphy (D) signed legislation to restrict hemp products, adding sickle cell anemia as a medical cannabis qualifying condition and extending labor rights to marijuana industry workers. Separately, lawmakers sent the governor legislation to revise Cannabis Regulatory Commission rules and crack down on unlicensed marijuana sales. New York Gov. Kath Hochul (D) proposed cannabis-related initiatives in her State of the State address, including to create a certified business incubator hub network, a workforce development partnership, a pro bono legal aid initiative and a Center of Excellence for Medical Cannabis and Health Equity. The Pennsylvania Center for Rural Pennsylvania will hold a hearing about hemp issues on Thursday. Florida’s secretary of state is urging a judge to reject a marijuana legalization campaign’s lawsuit challenging moves to throw out more than 70,000 petition signatures over alleged violations. Kansas’s House minority leader said legalizing marijuana could be a way to raise revenue to pay for other Democratic agenda items. The Massachusetts Ballot Law Commission held a pre-hearing conference about complaints of fraudulent signature gathering for a proposed ballot initiative to roll back marijuana legalization. Oregon regulators sent guidance about new hemp rules that took effect on January 1. Connecticut officials reached a settlement with marijuana companies to resolve allegations they violated merger laws. Maryland regulators published a list of certified cannabis testing laboratories. Montana regulators sent updates on various cannabis issues. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL British Columbia, Canada officials are expected to reveal soon whether they plan to apply for an extension of federal permission for a local drug decriminalization trial. / SCIENCE & HEALTH A review concluded that “besides epilepsy, preclinical data suggest that CBD alone may be potentially beneficial in treating chronic pain, multiple sclerosis, Alzheimer’s and Parkinson’s diseases, or stroke.” A study “provides a crucial first step toward understanding the evolutionary role of psilocybin-producing fungi.” / ADVOCACY, OPINION & ANALYSIS The Honolulu Star-Advertiser editorial board criticized a proposal to put marijuana legalization on Hawaii’s ballot as a constitutional amendment. / BUSINESS Mind Medicine is rebranding as Definium Therapeutics, Inc. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Federal hemp THC ban would be delayed for two years under new bill (Newsletter: January 14, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I admire this article for the well-researched content and excellent wording. I got so involved in this material that I couldn’t stop reading. I am impressed with your work and skill. Thank you so much. sabung ayam resmi Wow, What an Outstanding post. I found this too much informatics. It is what I was seeking for. I would like to recommend you that please keep sharing such type of info.If possible, Thanks. togel online Yes, I am entirely agreed with this article, and I just want say that this article is very helpful and enlightening. I also have some precious piece of concerned info !!!!!!Thanks. omacuan game online It is my first visit to your blog, and I am very impressed with the articles that you serve. Give adequate knowledge for me. Thank you for sharing useful material. I will be back for the more great post. slot deposit 5000

Do I Need to Wager the Bonus? Yes. Both the standard and promo bonuses have wagering requirements 1xbet free spins promo code thailand

They bring so much energy and positivity into breaking stereotypes and encouraging equality Image to Image AI

This service makes things very easy for busy people who need quick support. WhatsApp booking saves time and avoids long waiting. The staff replies fast and keeps all details simple and clear. I like how they respect privacy and handle communication calmly. When searching online, Escorts Delhi feels more dependable because the process is smooth and well managed. It is a good choice for anyone who values fast response and honest service.

Excited to see Tressa Yonekawa Bundren speak at this meetup! Just like in stickman hook, where timing and mindfulness are crucial to navigate through challenges, the principles of mindfulness she’ll discuss can really help entrepreneurs in the cannabis industry.

As Indiana lawmakers again look to reform state marijuana policy in the 2026 session, a new poll finds that nearly three in five residents back legalizing cannabis for medical and recreational use. The annual Hoosier Survey from the Bowen Center at Ball State University (BSU) asked 600 Indianans about a variety of policy issues, from congressional redistricting to marijuana legalization. It found that 59 percent of residents are in favor of legalizing cannabis for both medical and recreational purposes. An additional 25 percent back only allowing patients to access medical marijuana, raising the total support for that reform to 84 percent. “In the last year or two, you’ve seen almost exponential growth in support, and then non-traditional support, and by that, I mean business leaders [and] parents—not your traditional college-age kid or high school person,” Andrew Bauman, executive director of The Bowen Center, told Inside Indiana Business. The survey was released just days after Indiana Rep. Mitch Gore (D) filed legislation that would effectively legalize the possession and cultivation of limited amounts of marijuana. It’s one of several reform options on the table so far in the legislature for this year’s session. Whether legislators ultimately take up any of the pending measures is yet to be seen, but cannabis reform advocates have generally struggled to make inroads in the conservative legislature over recent years. That said, the state’s GOP governor said recently that a move by President Donald Trump to federally reschedule marijuana could add “a little bit of fire” to the local push for cannabis legalization in his state. Months later, Trump did sign an executive order directing the attorney general to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). Gov. Mike Braun (R) also said last year that he’s “amenable” to medical cannabis legalization. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, one member of the state’s congressional delegation, Sen. Jim Banks (R-IN), expressed opposition to state-level reform despite Trump’s prior comments previewing a rescheduling decision. “President Trump has been honest about it, that when it comes to marijuana, he said very clearly we shouldn’t smell it on the streets. You have a lot of states that have legalized it. It’s caused even more crime and issues,” Banks said. “I hope Indiana is never a state that legalizes marijuana, by the way.” The senator acknowledged, however, that there is likely to be “further conversation” about the issue. Braun, for his part, previously said that “it’s probably time” to allow access to therapeutic cannabis among patients in the state. Those comments came alongside a separate poll indicating that nearly 9 in 10 Indiana adults (87 percent) support marijuana legalization. Top Republicans in the legislature, however, have openly opposed marijuana reform. “It’s no secret that I am not for this,” Senate President Pro Tem Rodric Bray (R) said in late 2024. “I don’t have people coming to me with really compelling medical cases as to why it’s so beneficial. And any state that I’ve seen pass medical marijuana is essentially passing recreational marijuana.” House Speaker Todd Huston (R) doubted any medical benefits associated with marijuana, calling the substance “a deterrent to mental health.” He and others suggested that lawmakers supportive of the reform merely want to boost state revenue. A number of marijuana reform bills were introduced for the Indiana legislature’s 2025 session, including one—from Reps. Jim Lucas (R) and Shane Lindauer (R)—that would have legalized medical marijuana for people with “serious medical conditions as determined by their physician.” The post 3 In 5 Indiana Residents Support Marijuana Legalization, New Poll Finds As State Lawmakers File Reform Bills appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“These initiatives represent the first-ever large-scale coordinated attack on adult-use markets… This is not a drill. It is the moment to come together to defeat the prohibitionists.” By Adam Smith, Marijuana Policy Project 2025 felt like a year of waiting in cannabis, but 2026 may be something else entirely. Get ready for a major pushback against adult-use markets. While much of the cannabis world spent month after month in 2025 watching (or lobbying) Congress on hemp, and the White House on rescheduling, three near-identical state ballot initiatives were being filed for the November 2026 election that would end regulated adult-use sales in Massachusetts, Maine and Arizona. The Massachusetts and Maine initiatives would also re-criminalize non-medical home grow. The Massachusetts campaign has submitted enough signatures to qualify, and awaits validation. Signature collection is ongoing in Maine and Arizona. While it’s possible that one or more of these initiatives fail to make the ballot, it’s imperative that we take them seriously and prepare for a fight. These are not symbolic protests or fringe efforts. They are coordinated campaigns run by experienced political operatives. And from the sound of it, they may already have a ton of money behind them. How Much? On December 19, the Arizona committee chair told the Arizona Capitol Times that the campaign expects to spend $5 million on signature gathering in the state, with an additional $10 to $20 million planned for the broader campaign. In Massachusetts, we estimate that at least $1 million was spent to gather signatures. Those numbers should get our attention. Meanwhile, over the past year, we saw a partially successful legislative push in Ohio to chip away at voter-approved adult-use legalization—though the Marijuana Policy Project (MPP) was on the ground and helped limit the damage—as well as similar legislative efforts elsewhere. In the media, fear-based coverage of cannabis dramatically increased across mainstream outlets in 2025, while targeted anti-legalization messaging across right-wing media has worked to soften Republican support. In fact, Gallup reports that Republican support for legalization has dropped from 55 percent to 40 percent since 2023. That’s Not A Coincidence. It’s A Playbook. MPP, which has led and won more cannabis ballot initiative campaigns than anyone on either side of this issue, is already working closely with industry allies in Massachusetts to launch a “No” campaign. We expect to do the same in Maine and Arizona. These initiatives represent the first-ever large-scale coordinated attack on adult-use markets. How we as a cannabis ecosystem respond, and particularly whether and how the national cannabis business community steps up to defend itself and each other, will determine whether this attempt to roll back our progress ends here, or whether it metastasizes. “End Regulated Adult-Use Markets? How Could They Possibly Win?” Campaigns do not commit resources at this level without internal polling and strategic modeling that shows a path to victory. And sure enough, in that same Capitol Times piece, the Arizona committee chair alluded to private polling that allegedly showed less than majority support for adult-use markets in the state. The orchestrated collapse of Republican support for legalization over the past two years offers them hope as well. And if adult-use shows weakness at the ballot box in November, combined with dwindling support for legalization among Republican voters—support that could erode further as prohibitionists use these campaigns to get their message out—it would significantly strengthen the prohibitionists’ hand within the administration, in Congress and in state legislatures across the country. This is not a drill. It is the moment to come together to defeat the prohibitionists and their initiatives so convincingly that their funders stop taking their calls. Making The Big Case MPP, as it has done successfully for more than 30 years, will lead here. And while there will obviously be tactical and messaging variance between states, the core question in all three campaigns is the same: whether regulated markets are safer, smarter and more effective than returning to prohibition. It’s an opportunity that we cannot afford to miss. As recent events have begun to turn the nation’s attention back to cannabis, these campaigns provide us with an opportunity to re-center and re-engage the public conversation—not just in three states, but nationally—around the benefits of regulation versus the harms of prohibition. That conversation will focus on protecting public health and safety, reduced youth access, increased personal freedom, rational law enforcement priorities and creating jobs, economic opportunity and state revenues. Making the case against prohibition on broad public policy grounds—particularly to reach and to move people who have no particular interest in cannabis or cannabis users—is advocacy’s sweet spot. It’s what we’ve done successfully for decades, and it’s why more than half of the U.S. population now lives in states with regulated markets. When we do that, and when we defeat these efforts—loudly and convincingly—the results will redound to all aspects of cannabis and cannabinoid policy reform everywhere in the country and at all levels of government. An Attack On Us All Make no mistake, this is an attack on the entire industry and cannabis users everywhere—and on legal cannabis itself—regardless of where you live or do business. With the far better argument on our side, we won’t need to outspend the prohibitionists to beat them. But we will need to be competitive. It’s going to require real resources to run campaigns capable of getting our message and our voters out. And while we know that everyone’s struggling, with tens of thousands of cannabis-aligned businesses and professionals in the crosshairs—licensees and allied businesses alike—success cannot and will not depend on a small handful of companies or individuals financing the effort, or upon whether a single state’s industry can raise more or less money to defend themselves. Rather, success will depend on whether the national cannabis business community stands up for themselves and for each other in a show of force by making some meaningful contribution to the common defense. Failure Is Not An Option If even one of these initiatives succeeds, it would send a dangerous signal that legal cannabis markets are politically reversible. And that signal would not stop at state borders. It would ripple through capital markets, transactions, insurance underwriting, lending decisions, expansion plans and legislative debates nationwide. As Dentons partners Joanne Caceres and Hannah King warned in a Marijuana Moment op-ed about the initiatives: “Imagine the signal sent to investors if legalization proves politically reversible. The risk premium on cannabis assets would skyrocket. Lenders, insurers, and ancillary service providers would likely pull back. M&A activity, already tepid, could stall.” Even coming close could encourage a second wave of initiatives in states across the country, each requiring significant resources to oppose. These initiatives need to be beaten and beaten soundly to put an end to this. All Together Now We cannot leave our brothers and sisters—cannabis consumers, business owners, investors, employees, advocates—in Massachusetts, Maine and Arizona to sink or swim on their own. It’s imperative that we stand with them. Not only because they might otherwise be overwhelmed by prohibitionist spending, but because if they sink, we might all drown. This year, in addition to both new and ongoing legislative work across multiple states, MPP is gearing back up into campaign mode to fight for the freedom of adults to buy safe, regulated cannabis. And for the future of the legal industry that provides it. Not just in Maine, Massachusetts, and Arizona, but everywhere. Adam Smith is executive director of the Marijuana Policy Project. The post Legal Marijuana Access Faces An Existential Threat In 2026, And We Must Fight Back (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New Jersey lawmakers have passed a bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the effort. Following its advancement through several House and Senate committees, both full chambers of the legislature approved the psychedelic measure on Monday, sending it to Gov. Phil Murphy (D). “Studies conducted by nationally and internationally recognized medical institutions indicate that psilocybin has shown efficacy, tolerability, and safety in the treatment of a variety of behavioral health conditions,” the bill’s findings sections says, “including, but not limited to, substance use disorders, depression, anxiety disorders, and end-of-life psychological distress.” The legislation, sponsored by Senate President Nick Scutari (D) and Sen. Joseph Vitale (D), along with Assemblymembers Clinton Calabrese (D) and Anthony S. Verrelli (D), would create an 11-member Psychedelic Therapy and Research Advisory Board to oversee the new Psilocybin Behavioral Health Services Pilot Program. “I think it’s a real opportunity for New Jersey to lead an area of medicine that is groundbreaking,” Scutari said, according to NorthJersey.com. Within 180 days of enactment, the Department of Health would be required to issue a request for proposals from hospitals that want to participate. One hospital from each of three geographic regions of the state would then be selected to receive $2 million to support psilocybin trials. “Under no circumstance shall the department establish, implement, or enforce a requirement, specification, or guideline under the pilot program that conflicts with protocols and guidelines from the United States Food and Drug Administration related to clinical trials for psychedelic substances,” the bill, whose passage was noted earlier by Heady NJ, says. After the two-year pilot program is completed, officials would submit reports to the governor and legislature including “recommendations concerning the continuation or expansion of the pilot program” as well as “recommendations as to the development and implementation of a comprehensive plan for State and local regulation of psilocybin to provide access in New Jersey for individuals who could benefit and that considers efficacy, safety, and affordability.” While the legislation as introduced would have more broadly legalized psilocybin for adult use, making it legal for adults to “possess, store, use, ingest, inhale, process, transport, deliver without consideration, or distribute without consideration, four grams or less of” the psychedelic, but it was scaled back during its advancement through the process. The amended measure would nevertheless significantly expand on legislation introduced in late 2020 to reduce penalties for possession of up to one ounce of psilocybin. That reform was signed into law by Gov. Phil Murphy (D) in 2021. Assemblywoman Lisa Swain (D), who chairs the Assembly Appropriations Committee, described the current amended bill last month as a “first step.” “I mean, you’ve heard the testimony here,” she said, referring to witnesses who argued that broader reform is needed. “This bill creates an advisory board that will be able to make determinations—for instance, whether it should be natural mushrooms or synthetic mushrooms. So that option is still on the table. It’s a pilot program and we want to get started to make sure that, as you heard, people who really need to be treated” can get access. A survey of New Jersey residents in 2024 indicated that a majority of state residents agree with making psilocybin available for therapeutic use. The poll, from Stockton University’s William J. Hughes Center for Public Policy, found that 55 percent of respondents supported legalizing psilocybin for medical use under a doctor’s supervision. Just 20 percent of respondents were opposed, while 24 percent said they weren’t sure. One percent of respondents refused to answer the question. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In other New Jersey drug policy news, voters in November elected U.S. Rep. Mikie Sherrill (D-NJ) to serve as the state’s next governor, and there’s now a decidedly clearer path to advancing a marijuana reform long awaited by consumers and advocates in the Garden State: A home grow option. Meanwhile, as New Jersey’s first marijuana consumption lounges opened up over the summer, regulators shared information about where to find the sites and offering tips about how to responsibly use cannabis at the licensed businesses—including classic stoner cultural customs like “puff, puff, pass.” New Jersey officials have also completed the curriculum of a no-cost marijuana training academy that’s meant to support entrepreneurs interested in entering the cannabis industry. Separately, last May Scutari filed a bill that would re-criminalize purchasing marijuana from unlicensed sources—one of the latest attempts to crack down on the illicit market and steer adults toward licensed retailers. Seemingly contradicting that claim, dozens of New Jersey small marijuana businesses and advocacy groups recently called on the legislature to allow adults to cultivate their own cannabis. The post New Jersey Legislature Passes Bill To Create Psilocybin Therapy Pilot Program, Sending It To Governor appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

In addition to welcome and promotional bonuses, the “Promo Code Store” is a permanent feature at 1xBet. how to use promo code in 1xbet somalia